Piperidinone Derivatives as MDM2 Inhibitors for the Treatment of Cancer
US-2026078091-A1 · Mar 19, 2026 · US
This page is not indexed by search engines while we improve data quality.
Low Jonathan D patents
Low Jonathan D is listed as an inventor on 48 patents in our database. Major assignees and classification codes are summarized below.
| Metric | Value |
|---|---|
| Inventor | Low Jonathan D |
| Total patents | 48 |
| First publication | Feb 17, 2015 |
| Latest publication | Mar 19, 2026 |
Notable patents
Publications ranked by popularity score, then publication date.
Heterocyclic compounds as delta-5 desaturase inhibitors and methods of use
US-12473289-B2 · Nov 18, 2025 · US
KRAS G12C inhibitors and methods of using the same
US-12440491-B2 · Oct 14, 2025 · US
Piperidinone Derivatives as MDM2 Inhibitors for the Treatment of Cancer
US-2024300892-A1 · Sep 12, 2024 · US
Substituted piperazines as KRAS G12C inhibitors
US-12083121-B2 · Sep 10, 2024 · US
Inhibitors of kras g12c and methods of using the same
US-2024287068-A1 · Aug 29, 2024 · US
Inhibitors of KRAS G12C and methods of using the same
US-11993597-B2 · May 28, 2024 · US
Kras g12c inhibitors and methods of using the same
US-2024050430-A1 · Feb 15, 2024 · US
KRAS G12C inhibitors and methods of using the same
US-11766436-B2 · Sep 26, 2023 · US
Kras g12c inhibitors and methods of using the same
US-2022395504-A1 · Dec 15, 2022 · US
Recent patents
Latest publications not already listed above.
Inhibitors of kras g12c and methods of using the same
US-2022213101-A1 · Jul 7, 2022 · US
Kras g12c inhibitors and methods of using the same
US-2022175782-A1 · Jun 9, 2022 · US
Piperidinone Derivatives as MDM2 Inhibitors for the Treatment of Cancer
US-2022169611-A1 · Jun 2, 2022 · US
Inhibitors of KRAS G12C and methods of using the same
US-11306087-B2 · Apr 19, 2022 · US
Substituted piperazines as KRAS G12C inhibitors
US-11285156-B2 · Mar 29, 2022 · US
Macrocyclic compounds that inhibit MCL-1 protein
US-11279712-B2 · Mar 22, 2022 · US
Compounds that inhibits MCL-1 protein
US-11224601-B1 · Jan 18, 2022 · US
KRAS G12C inhibitors and methods of using the same
US-11090304-B2 · Aug 17, 2021 · US
Piperidinone Derivatives as MDM2 Inhibitors for the Treatment of Cancer
US-2021179560-A1 · Jun 17, 2021 · US
Heterocyclic compounds as delta-5 desaturase inhibitors and methods of use
US-2021171529-A1 · Jun 10, 2021 · US
Cyclopropyl fused thiazine derivatives as beta-secretase inhibitors and methods of use
US-10889581-B2 · Jan 12, 2021 · US
Compounds that inhibit Mcl-1 protein
US-10821115-B2 · Nov 3, 2020 · US
Macrocyclic compounds that inhibit mcl-1 protein
US-2020247821-A1 · Aug 6, 2020 · US
Cyclopropyl fused thiazine derivatives as beta-secretase inhibitors and methods of use
US-2020231585-A1 · Jul 23, 2020 · US
Inhibitors of kras g12c and methods of using the same
US-2020207766-A1 · Jul 2, 2020 · US
Compounds that inhibit mcl-1 protein
US-2020171043-A1 · Jun 4, 2020 · US
Inhibitors of KRAS G12C and methods of using the same
US-10640504-B2 · May 5, 2020 · US
Compounds that inhibit Mcl-1 protein
US-10632128-B2 · Apr 28, 2020 · US
Compounds that inhibit mcl-1 protein
US-2019381064-A1 · Dec 19, 2019 · US
Kras g12c inhibitors and methods of using the same
US-2019374542-A1 · Dec 12, 2019 · US
Major assignees
Companies most often associated with this inventor's publications.
| Assignee | Patents |
|---|---|
| Amgen Inc | 50 |
| Minatti Ana Elena | 1 |
| Epstein Oleg | 1 |
| White Ryan | 1 |
| Weiss Matthew | 1 |
Top CPC classifications
Most common classification codes across this inventor's patents.
| CPC | Patents |
|---|---|
| A61P35/00 | 34 |
| C07D471/04 | 27 |
| A61P43/00 | 18 |
| C07D417/14 | 18 |
| C07D417/12 | 16 |